
What happened
A JAMA article, led by Ezekiel Emanuel and Vinod Khosla, concludes that autonomous AI alone will likely surpass doctors and human-AI hybrids in five core medical tasks — taking histories, diagnosing, ordering tests, prescribing, and managing chronic disease — by 2030. The authors reviewed published AI-in-medicine studies since January 1, 2024.
Why it matters
The paper argues that "humans in the loop degrade AI performance," so clinicians should step back. This challenges the prevailing hybrid model and has drawn criticism from AMA CEO John Whyte, who notes some studies were simulations and a February 2026 Nature article found patients struggled to use LLMs effectively. UCSF's Robert Wachter, though initially skeptical, concedes the argument is important, saying "there will be times when humans will muck up the performance."
What to watch
The paper predicts a "superior autonomous AI" will surpass humans using AI by 2030, a claim authors call "unsettling but seems probable." Neal Khosla expects AI will get regulatory permission to prescribe medicine in coming years. Meanwhile, concerns about "de-skilling" doctors are rising, as medical schools debate whether trainees should rely on AI tools.
Summaries like this, in your inbox every morning.
The article's bold prediction stems from a partnership between Emanuel, a prominent medical ethicist, and Khosla, a long-time AI advocate. For years, Khosla argued AI would do 85% of what doctors do by 2035, a claim Emanuel once dismissed as "bullshit." But after reading Wachter's book on AI and medicine, Emanuel began to reconsider. The resulting paper is not just a prediction; it actively advocates for removing humans from the loop, citing evidence that human involvement can degrade AI performance.
The pushback highlights a critical tension in medical AI. While some studies show AI's potential, real-world hurdles remain. The Nature study's finding that patients often can't use LLMs effectively points to a practical gap. Yet even skeptics like Wachter acknowledge the argument's force, suggesting that the hybrid model may not be permanent. The debate extends beyond medicine, raising existential questions about the role of human expertise in an AI-driven world.
The future likely involves a gradual shift. AI may first gain permission to prescribe, then take on more complex tasks. The "doorman fallacy" offers some comfort, suggesting doctors may find new roles beyond diagnosis. But for now, the JAMA article sets a clear timeline: by 2030, AI alone could provide the best care, leaving doctors to ask what's left for them.
Pick your industry and the AI tools you use, and get news related to your work every day.
Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.
OpenAI introduced the Rosalind Academic Plan, giving eligible academic labs at U.S

Santen Pharmaceutical's R&D division reached a 93% weekly usage rate for generative AI, applying it to study p…

Snowflake published a post on agentic AI across oncology's five stages, citing AstraZeneca cutting data produc…

A solo developer built Yurune, a web app that plays synthesized rain, wave and forest sounds and lets users ta…

Pharmaceutical Executive will host a November 4, 2026 webcast introducing the RAIL Score, a framework for eval…

Reuters reports that the pharma sector is doubling down on AI as a way to cut costs and timelines
